Algernon Pharmaceuticals Boosts Private Placement

Algernon Pharmaceuticals (TSE:AGN) has released an update.

Algernon Pharmaceuticals, a Canadian pharmaceutical development company, has announced an increase in their private placement from $150,000 to $235,200, offering units at $0.12 each, which includes a common share and a purchase warrant. The purchase warrants grant the holder the right to buy additional shares at $0.24 within two years, with the possibility of an accelerated expiry. Proceeds from the placement, expected to close on August 16, 2024, will fund the company’s working capital.

For further insights into TSE:AGN stock, check out TipRanks’ Stock Analysis page.